NCT Number: NCT00237965
The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy
This study aims to improve Skin Self-Examination accuracy by a simple cost effective intervention requiring participants to complete a mole-mapping diagram.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Male and female subjects above age 18 of any ethnicity will be enrolled in this study.
Exclusion criteria
- Subjects will be excluded from the study if they have significant skin disease which would not allow manipulation of their photographs consistent with the rest of the subjects.
- Since the study instructions are in English, Non-English speakers will be excluded.
- Those with co-morbidity sufficiently severe to prevent them from being able to perform a SSE will be excluded.
- In addition, those with cognitive impairment who are unable to give informed consent, or to understand the study instructions given to them, will be excluded.
Treatment and study plan
Sponsors and collaborators
Lead sponsor
Brown University
Other
Registry information
Important dates
- First posted
- Oct 13, 2005
- Registry last updated
- Oct 13, 2005
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer
NCT02718066
Adenocarcinoma, Bronchial Neoplasms
Phoenix, Arizona, United States
View Trial DetailsA Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma
NCT00429312
Melanoma, Neoplasms
Los Angeles, California, United States
View Trial DetailsValidation of ICG-99mTc-nanoscan as Hybrid Tracer for Sentinel Node Biopsy
NCT06666634
Genital Diseases, Genital Diseases, Male
Amsterdam, Netherlands
View Trial DetailsSelection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies
NCT02724488
Head and Neck Cancer, Head and Neck Neoplasms
View Trial Details